• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    188.87 -0.18 (-0.10%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Johnson & Johnson

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson Y-Axis Adjustment(R) (\"Ring Dinger(R)\") Clarified as In-Scope Care Under Texas Law; Advanced Chiropractic Equipment LLC Addresses Confusion with Y-Strap Traction
    Houston, Texas--(Newsfile Corp. - October 20, 2025) - Advanced Chiropractic Equipment LLC (ACE) and Your Houston Chiropractor, Gregory E. Johnson,... 
    Via Newsfile
    Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the UBS Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
    From Johnson & Johnson
    Via Business Wire
    Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
    EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    FDA Panel Reiterates the Cancer Risks of Talc
    From Beasley Allen Law Firm
    Via Business Wire
    Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
    From Johnson & Johnson
    Via Business Wire
    Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails
    From Nachawati Law Group
    Via Business Wire
    Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson expands efforts to champion the nursing workforce globally
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Reports Q1 2025 Results
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
    From Johnson & Johnson
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.